Top Performing Stocks - Invest Million

Acceleron Pharma (NASDAQ: XLRN) Rockets On Successful Phase 2 Study For PAH Treatment

Acceleron Pharma Inc (NASDAQ: XLRN) was a top gainer in yesterday’s trading session, and closed the day with gains of 50.16%. This followed the company’s announcement that, its mid-stage study for Sotatercept, its treatment candidate for people with PAH (Pulmonary Arterial

NASDAQ: MESO

Mesoblast Limited (NASDAQ: MESO) Surges Higher After Presentation At The 2020 Biotech Show In San Francisco

Mesoblast Limited (NASDAQ: MESO) was in the green on Friday, and closed the day with gains of 13%. This came after the company did a presentation for its commercial plans at the 2020 biotech show in San Francisco. In the presentation, the company

NASDAQ: TRIL

Trillium Therapeutics Inc (NASDAQ: TRIL) Rallies After Positive Data On TTI-621 Dosage

Trillium Therapeutics Inc (NASDAQ: TRIL) was a big gainer in yesterday’s trading session, and closed the day with gains of 93.96%. This came after the company announced progress on its TTI-621 and TTI-622 clinical programs. The CEO, Jan Skvarka announced that, the

NASDAQ: LIFE

A Tyr Pharma (NASDAQ: LIFE) Rallies After Collaborating With Kyorin Pharma For The Development Of ATYR1923

A Tyr Pharma Inc. (NASDAQ: LIFE) was a big gainer in yesterday’s trading session. The stock rallied to close the day with gains of 43.43%. This came after it announced a collaboration agreement with Kyorin Pharmaceuticals Co Ltd, for the development

Investments

CLPS Incorporation (NASDAQ: CLPS) Rallies After Integrating Two Singapore-Based Subsidiaries

CLPS Incorporation (NASDAQ: CLPS) was one of the top gainers just ahead of Christmas. The stock rallied to close the day with gains of 47.13%. This came after it announced that, it had completed the integration of Infogain Pte Ltd and RidKik Pte

Investments

Catalyst Biosciences Inc (NASDAQ: CBIO) Rallies After Announcing Global Collaboration With Biogen Inc

Catalyst BioSciences Inc (NASDAQ: CBIO) was one of the top gainers in yesterday’s trading session, and closed the day with gains of 65.83%. This came after it announced that, it had entered into a global license and collaboration with Biogen Inc.

NASDAQ: ONCY

Oncolytics Biotech (NASDAQ: ONCY) Sustains Gains Days After Positive News on Pelareorep, a Treatment For Solid Tumors

Oncolytics Biotech Inc (NASDAQ: ONCY) was a big gainer in Tuesday’s trading session, and closed the day with gains of 34.33%. This came a few days after the company announced acceptance of an abstract for a potential new biomarker data from the

Financial

Okta Inc (NASDAQ: OKTA) to Present at The 22nd Annual Needham Growth Conference in January 2020

Okta Inc (NASDAQ: OKTA) has been a top performer for the better part of 2019. Looking at its performance in the last 52-weeks, the stock is up 87.34%. A week ago, the company released its Q3 earnings, and they were higher than consensus

NASDAQ Stocks

Adial Pharmaceuticals (NASDAQ: ADIL) Rallies After Validating Bio-marker For AD04 Phase 3 Trial

Adial Pharmaceuticals, Inc (NASDAQ: ADIL) was one of the top gainers at the close of the week after is gained by 30.95% in Friday’s session. This followed the company’s announcement that, it had validated its genetic biomarker for the planned phase

Breaking News

Forty Seven Inc (NASDAQ: FTSV) Explodes on Myelodysplastic Syndrome and Acute Myeloid Leukemia Treatment Data

Forty Seven Inc (NASDAQ: FTSV) was one of the top gainers in Monday’s trading session. The stock rallied to close the day with gains of 110.73%. This came after the company released positive data about its ongoing trial for Myelodysplastic syndrome and

Gaining Stocks

Protagonist Therapeutics (NASDAQ: PTGX) Rallies after Announcing PTG-300 Phase 2 Trial Initial Results

Protagonist Therapeutics Inc (NASDAQ: PTGX) was one of the top gainers in Wednesday’s trading session. The stock rallied to close the day with gains of 72.92%. This came a day after it announced early results for its ongoing phase 2 study for

Breaking News

Alphabet Inc (NASDAQ: GOOG) Founding Duo Exits the Stage

Alphabet Inc (NASDAQ: GOOG) also popularly known as Google has today announced that, its two famous co-founders were stepping down. Larry Page and Sergey Brin will no longer be involved in the day-to-day affairs of the company. Instead, that role now goes to one

Gaining Stocks NYSE

IsoRay Inc (NYSE: ISR) Rallies as It Strengthens Leadership in the Prostate Brachytherapy Market

IsoRay Inc (NYSE: ISR) has been gaining upside momentum ever since it announced Q1 results for the fiscal year 2020. The company announced that it had a quarterly EPS loss of $0.01, much lower than analyst expectations of a loss of $0.02.

Gaining Stocks

Molecular Templates (NASDAQ: MTEM) Charges Forward on Funding News

Molecular Templates Inc (NASDAQ: MTEM) was one of the biggest gainers at the close of the week. On Friday, the stock rallied by 17.07% to close the week at $13.03. This followed news that the company had entered into a funding agreement

Gaining Stocks

SORL Auto Parts Inc (NASDAQ: SORL) Rallies on Buyout Deal

SORL Auto Parts Inc (NASDAQ: SORL) was one of the big gainers in Friday’s trading session. The stock gapped up to close the day with gains of 30.38%. This followed news that the company had agreed to a buyout deal at a

Breaking News

Can-Fite Biopharma Ltd (NYSE: CANF) Rallies on Positive News about Liver Cancer Treatment

Can-Fite Biopharma Ltd (NYSE: CANF) has been gaining steadily for the last few days. At the time of writing, the stock is up by 31.12% to trade at $3.36. Its upside momentum is driven by positive sentiment after it announced Q3 results.

Hot Stocks

ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) Rallies Days after ASLAN003 is Published in Haematologica Journal

ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) was among the top gainers in Wednesday’s trading session. The stock closed the day with gains of 81.25% percent and on high volumes of 15.36 million. The company has been gaining recently after an announcement that

Breaking News

Chemocetryx Inc (NASDAQ: CCXI) Rallies By Over 200% As Trial Treatment Shows Potential

ChemoCentryx Inc (NASDAQ: CCXI) was one of the biggest gainers in Tuesday’s trading session. The stock shot up by 281.27% to close the day at $30.73. This followed news that the company’s treatment candidate showed potential in the treatment of

Investments

Sorrento Therapeutics Inc (NASDAQ: SRNE) Rallies By Over 90% After Rejecting A Buy-Out Offer

Sorrento Therapeutics Inc (NASDAQ: SRNE) was one of the biggest gainers in Monday’s trading session. The stock closed the day with gains of 94.37%. This followed news that the company had rejected a buyout offer from two unnamed companies. The two companies

Investments

Akebia Therapeutics (NASDAQ: AKBA) Trades Higher on Disclosure of Insider Buying

Akebia Therapeutics, Inc [NASDAQ: AKBA] closed last week on a high note. The stock gained by 21.6% to close the week at $4.21. This followed an SEC disclosure that two of the company’s directors, Cynthia Smith and Steven Gilman, had

NYSE: SSI

Stage Stores (NYSE: SSI) Spikes Higher as its Conversion to Off-Price Gains Momentum

Stage Stores Inc [NYSE: SSI] was one of the big winners in Friday’s session. The stock rallied and closed the day with gains of 37.46%. This followed impressive Q3 earnings that beat analysts’ expectations. Stage Stores announced that sales in the quarter